Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase II Study to Establish the Efficacy of Synthetic Human SecretiN in Human Acute Pancreatitis (SNAP) Study

NCT03686618 is registered in ClinicalTrials.gov with ChiRhoClin, Inc. as lead sponsor.

NCT NCT03686618
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03686618 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase II Study to Establish the Efficacy of Synthetic Human SecretiN in Human Acute Pancreatitis (SNAP) Study
Lead sponsor
ChiRhoClin, Inc.
Phase
Phase 2
Overall status
Unknown status
Start date
October 1, 2018
Completion date
November 1, 2019
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pancreatitis, acute